Technology

LightningWire
- Proprietary insulation design optimizes electrosurgical performance and mechanical properties along the length of the wire
- Robust distal insulation allows transseptal puncture at low power settings, starting at 15 W1
- 0.032‑inch labeled diameter facilitates broad compatibility with various transseptal devices, including Agilis™ and Swartz™ SL1™
- More than 2× stiffer than the market‑leading 0.035‑inch guidewire to support transseptal delivery of bulky ablation and structural heart devices2

Activation Cable
- Connects to separately cleared electrosurgical generators via industry‑standard monopolar accessory ports
- Does not require a dedicated electrosurgical generator
- Designed to activate only desirable "cut" RF waveforms; cannot activate undesirable "coag" waveforms, which might lead to unwanted thrombus generation3
- Puts control of radiofrequency energy in the operator’s hands on the sterile field, including audible and haptic feedback
Why LightningWire

Efficiency
- Guidewire‑based transseptal puncture minimizes catheter exchanges
- Activation Cable immediately disconnects after transseptal puncture to enable therapy device delivery
- Visible markers facilitate fluoroscopy‑free workflows

Safety
- Compared to crossing at higher power settings, such as 50 W, lower power settings have been associated with reduced thermal injury to inter‑atrial septal tissue4
- Pigtail tip shape minimizes risk of cardiovascular injury after transseptal puncture5

Value
- Since existing electrosurgical generators may be used, capital expense may be eliminated
- Disposable cost is competitive with alternatives
Ordering Information
| System | Item No. | Contents |
|---|---|---|
| LightningWire TPS — 180 cm | 01‑180 | 180‑cm LightningWire, Activation Cable, and Tip Straightener |
| LightningWire TPS — 260 cm | 01‑260 | 260‑cm LightningWire, Activation Cable, and Tip Straightener |
For important safety information, click or tap here.
References
- LightningWire™ Transseptal Puncture System Instructions for Use (Rev C, April 2026).
- Data on file at ElectroWire Medical.
- J Am Coll Cardiol 2020 March 31; 75(12): 1455–1470.
- J Cardiovasc Electrophysiol 2022;33:371–379.
- J Am Coll Cardiol 1985;5:904–10; EuroIntervention 2013;8:1019–1025; J Interv Cardiol 2015;28(5):472–8.
